Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Finlay Macrae

Showing results (131-140 of 151) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|November 1, 2011
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialJohn Burn, Anne-Marie Gerdes, Finlay Macrae, et al.
Gut|December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut|June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Plos One|July 28, 2010
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinicsDaniel D Buchanan, Kevin Sweet, Musa Drini, et al.
Hereditary Cancer in Clinical Practice|October 20, 2017
Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database reportToni Seppälä, Kirsi Pylvänäinen, Dafydd Gareth Evans, et al.
JBI Evidence Implementation|February 24, 2026
Comparing theory-driven and intuition-based approaches to inform implementation strategies in practice: an exploratory two-arm cluster-randomized head-to-head implementation trialJulia Steinberg, Priscilla Chan, Sarsha Yap, et al.
Gut|July 30, 2017
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome DatabasePål Møller, Toni T Seppälä, Inge Bernstein, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Journal of Clinical Medicine|July 26, 2020
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome DatabaseMev Dominguez-Valentin, Toni T Seppälä, Christoph Engel, et al.
Hereditary Cancer in Clinical Practice|October 23, 2019
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reportMev Dominguez-Valentin, Toni T Seppälä, Julian R Sampson, et al.
Pageof 16

Showing results (131-140 of 151) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|November 1, 2011
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialJohn Burn, Anne-Marie Gerdes, Finlay Macrae, et al.
Gut|December 15, 2015
Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Gut|June 5, 2016
Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome databasePål Møller, Toni Seppälä, Inge Bernstein, et al.
Plos One|July 28, 2010
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinicsDaniel D Buchanan, Kevin Sweet, Musa Drini, et al.
Hereditary Cancer in Clinical Practice|October 20, 2017
Colorectal cancer incidence in <i>path_MLH1</i> carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database reportToni Seppälä, Kirsi Pylvänäinen, Dafydd Gareth Evans, et al.
JBI Evidence Implementation|February 24, 2026
Comparing theory-driven and intuition-based approaches to inform implementation strategies in practice: an exploratory two-arm cluster-randomized head-to-head implementation trialJulia Steinberg, Priscilla Chan, Sarsha Yap, et al.
Gut|July 30, 2017
Cancer risk and survival in <i>path_MMR</i> carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome DatabasePål Møller, Toni T Seppälä, Inge Bernstein, et al.
Journal of the National Cancer Institute|December 24, 2009
Risks of Lynch syndrome cancers for MSH6 mutation carriersLaura Baglietto, Noralane M Lindor, James G Dowty, et al.
Journal of Clinical Medicine|July 26, 2020
Risk-Reducing Gynecological Surgery in Lynch Syndrome: Results of an International Survey from the Prospective Lynch Syndrome DatabaseMev Dominguez-Valentin, Toni T Seppälä, Christoph Engel, et al.
Hereditary Cancer in Clinical Practice|October 23, 2019
Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database reportMev Dominguez-Valentin, Toni T Seppälä, Julian R Sampson, et al.
Pageof 16